Ignite Creation Date:
2025-12-25 @ 12:23 AM
Ignite Modification Date:
2025-12-25 @ 10:28 PM
Study NCT ID:
NCT01112358
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2010-04-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lutropin Alfa in Women at Risk of Poor Response
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IMP26170 (INI25954)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None